The Characterization of Blood Volumes of Commercially Available Lancing Devices

CompletedOBSERVATIONAL
Enrollment

64

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Diabetes
Interventions
DEVICE

Delica Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Flash Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Easy Touch Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Glucoject Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Microlet Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Multiclix Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Fastclix Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

DEVICE

Reli-On Lancing Device

Characterize Blood Volume and Pain under normal use circumstances

Trial Locations (1)

30144

Facet Technologies, Kennesaw

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

LifeScan

INDUSTRY

lead

Facet Technologies

OTHER

NCT01914302 - The Characterization of Blood Volumes of Commercially Available Lancing Devices | Biotech Hunter | Biotech Hunter